In this study, a 46-year-old female patient was presented with thyroid inflammatory myofibroblastic tumor that developed after COVID-19. Another notable point in the case is that her mother had ...

ABSTRACT: Inflammatory myofibroblastic tumor has been referred to by many different names in the past, such as plasma cell granuloma, inflammatory pseudotumor, fibrous histiocytoma, fibroxanthoma, ...

The study found that once a tumor formed, female fruit flies' immune cells (hemocytes) produced more of an inflammatory response signal than their male counterparts. This signal protein ...

Department of Chemistry, Beckman Institute for Advanced Science and Technology, and Cancer Center at Illinois, University of Illinois Urbana−Champaign, Urbana, Illinois 61801, United States ...

Chronic inflammation has become a key factor in the development of cancers in the gastrointestinal (GI) tract, which includes the stomach, intestines, pancreas, and other parts of the digestive ...

For colorectal cancer—one of the most common and lethal forms of the disease—groundbreaking research is revealing how chronic inflammation, driven in part by what we eat, fuels tumor growth ...

Colorectal cancer's characteristic tumors are spurred on by chronic inflammation, and new research shows this might be linked to a diet of ultra-processed foods high in unhealthy oils. In colorectal ...

The pathology of BP is linked to autoantibodies that target two hemidesmosomal proteins: BP180 and BP230. Melanomas are malignant tumors originating from melanocytes that can appear on any part of the ...

The subject of inflammation, forming, as it does, the fundamental basis of pathology, and it might be said also of the science and practice of medicine, is beset with difficulties. The literature ...

Comparison of laparoscopic radiofrequency ablation with percutaneous radiofrequency ablation in the treatment of chronic hepatitis B-related hepatocellular carcinoma involving specific sites: A ...

irrespective of tumor histology. Using multiplex polymerase chain reaction (PCR) next-generation sequencing, NCI-MATCH genotyped 5,540 patients, discovering gene fusions in 202/5,540 tumors (3.65%).